Dr. Klem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1017 S Travis Ave
Cleveland, TX 77327Phone+1 281-592-5411Fax+1 409-835-1220
Education & Training
Baylor College of MedicineFellowship, Interventional Cardiology, 2001 - 2002- Baylor College of MedicineFellowship, Cardiovascular Disease, 1998 - 2001
Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Oklahoma College of MedicineClass of 1995
Certifications & Licensure
TX State Medical License 2001 - 2025
Publications & Presentations
PubMed
- 36 citationsPlatelet–monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with αIIbβ3 and αMβ2, in coronary stentingLaura S Fernandes, Ian del Conde, C. Wayne Smith, Geoffrey S. Kansas, Karen R. Snapp
Thrombosis Research. 2003-01-01 - 22 citationsPharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide.Neal S. Kleiman, Jeffrey A Klem, Laura S Fernandes, Howard Stanton Rubin, Sarma Challa
American Heart Journal. 2002-04-01 - 12 citationsDetection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.Jeffrey A. Klem, Julie V. Schaffer, Paul D. Crane, John A. Barrett, Glen A. Henry
Journal of Nuclear Cardiology. 2000-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
